DrugApr 17, 2024
NATCO Pharma Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats recall — FDA D-0438-2024
CGMP Deviations
Class IIFDA: TerminatedNATCO Pharma Limited
Recall history in this database
Classification mix: Class II: 2.
DrugFeb 14, 2024
NATCO Pharma Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle recall — FDA D-0318-2024
CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were…
Class IIFDA: TerminatedNATCO Pharma Limited
Understanding this recall history
This page summarizes recall records in which the official source identifies NATCO Pharma Limited as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.